PDEX
PRO DEX INCCompany Information
- Company Name
- PRO DEX INC
- CIK
- CIK0000788920
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PDEX: Nasdaq
- Fiscal Year End
- June 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- PDEX
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-11
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 27,426
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 728,303
- Shares outstanding
- 3,225,884
- Ownership
- 22.58%
Earnings Market Reaction
- Filing date
- 2026-09-03
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash Equivalents At Carrying Value | 8 | 10 | 8 | 1 | 0 | 4 | 0 | 3 | 3 | 3 | 1 | 2 | ||||||
| Short Term Investments | 1 | 1 | 1 | 10 | 7 | 5 | 5 | 5 | 4 | 5 | 6 | 1 | ||||||
| Accounts Receivable Net Current | 21 | 19 | 18 | 18 | 16 | 16 | 18 | 13 | 14 | 13 | 13 | 11 | ||||||
| Deferred Costs Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Income Tax Receivable | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Inventory Net | 21 | 22 | 22 | 22 | 22 | 23 | 20 | 17 | 15 | 14 | 15 | 16 | ||||||
| Income Taxes Receivable | 1 | 0 | 0 | 0 | 1 | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | - | 1 | 0 | 0 | - | 1 | 1 | 0 | - | 1 | 1 | 0 | ||||||
| Prepaid Expense Current | 1 | - | - | - | 0 | - | - | - | 0 | - | - | - | ||||||
| Assets Current | 53 | 54 | 49 | 51 | 47 | 50 | 44 | 39 | 37 | 36 | 37 | 31 | ||||||
| Property Plant And Equipment Other Net | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Property Plant And Equipment Net | 5 | - | - | - | 5 | - | - | 5 | 5 | 5 | 5 | 5 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Tax Assets Net | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | - | - | - | ||||||
| Investments | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Goodwill | - | 7 | - | - | - | - | - | - | - | - | - | - | ||||||
| Long Term Investments | 1 | - | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 2 | 2 | 5 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 75 | 75 | 62 | 64 | 61 | 64 | 60 | 54 | 52 | 51 | 51 | 50 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 5 | 4 | 4 | 5 | 6 | 6 | 4 | 5 | 3 | 3 | 3 | ||||||
| Accrued Liabilities Current | 4 | 4 | 4 | 4 | 3 | 4 | 5 | 4 | 3 | 3 | 3 | 3 | ||||||
| Accrued Income Taxes Current | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | - | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | - | - | ||||||
| Notes Payable Current | 4 | 4 | 2 | 5 | 6 | 8 | 6 | 2 | 4 | 4 | 4 | 3 | ||||||
| Liabilities Current | 13 | 15 | 12 | 14 | 15 | 18 | 17 | 11 | 13 | 10 | 10 | 8 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Deferred Income Tax Liabilities Net | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Notes Payable | - | - | - | - | - | - | - | - | 8 | 8 | 8 | 9 | ||||||
| Long Term Notes Payable | - | 14 | 8 | 9 | - | 10 | 10 | 11 | - | - | - | - | ||||||
| Liabilities Noncurrent | 14 | 15 | 8 | 9 | 10 | 11 | 11 | 12 | 9 | 9 | 10 | 10 | ||||||
| Liabilities | 27 | 30 | 21 | 23 | 25 | 29 | 29 | 23 | 22 | 20 | 20 | 18 | ||||||
| Common Stock Value | - | - | - | 1 | 1 | 1 | 0 | 1 | 4 | 6 | 7 | 7 | ||||||
Stockholders Equity | ||||||||||||||||||
| Retained Earnings Accumulated Deficit | 48 | 45 | 42 | 41 | 36 | 35 | 31 | 29 | 27 | 25 | 25 | 24 | ||||||
| Stockholders Equity | 48 | 45 | 42 | 42 | 37 | 35 | 32 | 31 | 31 | 31 | 32 | 31 | ||||||
| Liabilities And Stockholders Equity | 75 | 75 | 62 | 64 | 61 | 64 | 60 | 54 | 52 | 51 | 51 | 50 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | 0 | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
| Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | ||||||
| Shares Outstanding | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPRO DEX INC (PDEX) — SEC Financial Statements & Analysis
PRO DEX INC (PDEX) is a surgical & medical instruments & apparatus company. PRO DEX INC trades on Nasdaq as: PDEX. PRO DEX INC (PDEX)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-03. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), PRO DEX INC carries a market cap of $188.88M, a P/E ratio of 13.82x, a P/B ratio of 3.97x, a P/S ratio of 2.44x, an enterprise value of $184.89M, and an EV/EBITDA multiple of 12.85x. On profitability, it posts a gross margin of 31.38%, an operating margin of 16.75%, a net margin of 17.62%, a Return on Equity (ROE) of 32.43%, a Return on Assets (ROA) of 20.14%, and a Return on Invested Capital (ROIC) of 29.53%. Per share, it reports EPS of $4.24, diluted EPS of $4.12, free cash flow per share of $2.16, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 16.45% year-over-year, net income growth of 52.17% year-over-year, and EPS growth of 55.09% year-over-year. On the balance sheet, it maintains a current ratio of 4.10x, a quick ratio of 2.41x, working capital of $40.27M, a debt-to-equity ratio of 0.56x, a debt ratio of 0.36, an interest coverage ratio of 23.97x, free cash flow of $6.96M (TTM), and net debt of $-3.99M. Figures sourced from SEC EDGAR.
- Market Cap
- $188.88M
- P/E TTM
- 13.82x
- EPS TTM
- $4.24
- P/B TTM
- 3.97x
- ROE TTM
- 32.43%
- ROA TTM
- 20.14%
- Debt To Equity
- 0.56x
- Free Cash Flow TTM
- $6.96M
- Net Revenue TTM Growth 1Y
- 16.45%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PRO DEX INC in?
PRO DEX INC (PDEX) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does PDEX trade on?
PRO DEX INC (PDEX) trades on the Nasdaq.
When was PRO DEX INC (PDEX)'s most recent SEC filing?
PRO DEX INC (PDEX)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-03.
What is PDEX's market cap?
PRO DEX INC (PDEX) has a market capitalization of $188.88M as of 2026-06-30.
What is PDEX's P/E ratio?
PRO DEX INC (PDEX)'s trailing twelve month P/E ratio is 13.82x as of 2026-06-30.
What is PDEX's EPS (earnings per share)?
PRO DEX INC (PDEX)'s trailing twelve month EPS is $4.24 as of 2026-06-30.
What is PDEX's ROE (return on equity)?
PRO DEX INC (PDEX)'s trailing twelve month Return on Equity (ROE) is 32.43% as of 2026-06-30.
What is PDEX's ROA (return on assets)?
PRO DEX INC (PDEX)'s trailing twelve month Return on Assets (ROA) is 20.14% as of 2026-06-30.
What is PDEX's ROIC (return on invested capital)?
PRO DEX INC (PDEX)'s trailing twelve month Return on Invested Capital (ROIC) is 29.53% as of 2026-06-30.
What is PDEX's EV/EBITDA?
PRO DEX INC (PDEX)'s trailing twelve month EV/EBITDA is 12.85x as of 2026-06-30.